Go

Breaking News on Cosmetics Formulation & Packaging - North America EU edition

All feeds

Headlines > Formulation & Science

News in brief

Jan Marini criticizes eyelash enhancing drug from Allergan

22-Jan-2009

Related topics: Formulation & Science

Jan Marini Skin Research has hit out against the new eyelash enhancing drug from Allergan, which gained regulatory approval from the FDA last month.

Commenting Allergan’s Latisse eyelash enhancer, Jan Marini, the CEO of Jan Marini Skin Research, said its Marini Lash Eyelash Conditioner is a safe and cost effective alternative to the new product.

"With Marini Lash, anyone can have thicker and lusher-appearing lashes without the substantial cost or warning labels that accompany the Latisse prescription product,” said Marini.

Allergan won regulatory approval for Latissse after an FDA advisory panel ruled that available data demonstrated the drug’s power to make eyelashes longer and thicker without serious side-effects.